205 results on '"Naegel, Steffen"'
Search Results
2. Evidence for converging pathophysiology in complex regional pain-syndrome and primary headache disorders: results from a case–control study
3. Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
4. Vertebrobasilar artery elongation in migraine—a retrospective cross-sectional study
5. Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany
6. Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
7. Different K+-release in distal myogenic and neurogenic muscular weakness during non-ischemic exercise
8. Headache and migraine in mitochondrial disease and its impact on life—results from a cross-sectional, questionnaire-based study
9. Migraine and Stroke
10. Evidence for converging pathophysiology in complex regional pain-syndrome and primary headache disorders: results from a case–control study
11. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial
12. Reduced vestibular perception thresholds in persistent postural-perceptual dizziness- a cross-sectional study
13. Preventive treatment with CGRP monoclonal antibodies restores brain stem habituation deficits and excitability to painful stimuli in migraine: results from a prospective case-control study
14. Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
15. Cognitive deficits in patients with peripheral vestibular dysfunction
16. Cerebral gray matter changes in persistent postural perceptual dizziness
17. Erenumab in highly therapy-refractory migraine patients: First German real-world evidence
18. Role of Functional Neuroimaging in Primary Headache Disorders
19. Improvements in walking distance during nusinersen treatment : a prospective 3-year SMArtCARE registry study
20. Cognitive deficits in patients with peripheral vestibular dysfunction
21. Polarity-specific modulation of pain processing by transcranial direct current stimulation – a blinded longitudinal fMRI study
22. 086 Long-term efficacy of fremanezumab in migraine patients with inadequate response to prior preventive medication classes
23. Vertebrobasilar artery elongation in migraine—a retrospective cross-sectional study
24. Study Design and Protocol of a Randomized Controlled Trial of the Efficacy of a Smartphone-Based Therapy of Migraine (SMARTGEM)
25. Changes in Heart Rate and Blood Pressure in Participants Treated With Fremanezumab for Migraine: A Pooled Analysis of Phase 3 Studies (P3-2.003)
26. Gray matter volume reduction reflects chronic pain in trigeminal neuralgia
27. 43 - Migraine and Stroke
28. Influences of smoking and caffeine consumption on trigeminal pain processing
29. Patient-conducted anodal transcranial direct current stimulation of the motor cortex alleviates pain in trigeminal neuralgia
30. The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine
31. Response to the Letter to the Editor by Arshad and Bronstein “Motion perception in vestibular migraine”
32. Structural Imaging in Cluster Headache
33. Sensitized rotatory motion perception and increased susceptibility to motion sickness in vestibular migraine: A cross‐sectional study
34. Additional file 1 of Reduced vestibular perception thresholds in persistent postural-perceptual dizziness- a cross-sectional study
35. Additional file 1 of Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
36. Erenumab for migraine prevention in a patient with mitochondrial encephalopathy, lactate acidosis, and stroke‐like episodes syndrome: A case report
37. Headache Attributable to Nonvascular Intracranial Disorders
38. No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study.
39. Reduced Vestibular Perception Thresholds in Persistent Postural-Perceptual Dizziness- A Cross-Sectional Study
40. Prevalence and risk factors of migraine and non-migraine headache in older people – results of the Heinz Nixdorf Recall study
41. sj-pdf-2-cep-10.1177_0333102420977183 - Supplemental material for Prevalence and risk factors of migraine and non-migraine headache in older people – results of the Heinz Nixdorf Recall study
42. sj-pdf-1-cep-10.1177_0333102420977183 - Supplemental material for Prevalence and risk factors of migraine and non-migraine headache in older people – results of the Heinz Nixdorf Recall study
43. Neurotoxic cerebral oedema following coronary angiography
44. Hypothalamic Gray Matter Volume Loss in Hypnic Headache
45. Erenumab in highly therapy-refractory migraine patients First German Real-world evidence
46. Erenumab in Highly Therapy-refractory Migraine Patients: First Real-world Evidence
47. Contributors
48. Chronic and Primary Daily Vestibular Migraine - Two New Subtypes of the Disorder (P3.111)
49. Vestibular Perceptual Threshold and Motion Sensitivity in Vestibular Migraine and Persistent Postural-Perceptual Dizziness (P2.157)
50. Polarity-specific Modulation of Central Pain Processing by Transcranial Direct Current Stimulation (P2.100)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.